Synthesis and anti-SARS-CoV-2 potential of novel coumarin hybrids: a combined wet/dry lab approach targeting MPro, Nsp15 and spike protein

Rukhsana Kausar, Asim Mansha, Ameer Fawad Zahoor and Muhammad Haroon

RSC Adv., 2025, 15, 18577
DOI: 10.1039/D5RA02615F

Synthesis, Molecular Electron Density Theory Study, Molecular Docking, and Pharmacological Evaluation of New Coumarin–Sulfonamide–Nitroindazolyl–Triazole Hybrids as Monoamine Oxidase Inhibitors

Mohammed Eddahmi, Gabriella La Spada, Luis R. Domingo, Gérard Vergoten, Christian Bailly, Marco Catto and Latifa Bouissane

IJMS, 2024, 25, 6803
DOI: 10.3390/ijms25126803

Molecular pathways: the quest for effective MAO-B inhibitors in neurodegenerative therapy

Mega Obukohwo Oyovwi, Onoriode Andrew Udi, Adedeji David Atere, Gregory Uchechukwu Joseph and Udoji Godsday Ogbutor

Mol Biol Rep, 2025, 52
DOI: 10.1007/s11033-025-10349-x

Exploring the potential role of GyrA inhibiting quinoline analog: an in silico study

Soumyadip Ghosh and Sudha Ramaiah

Sci Rep, 2025, 15
DOI: 10.1038/s41598-025-04409-2

Current pharmacophore based approaches for the development of new anti-Alzheimer’s agents

Prachi Sharma, Sunil Sharma, Yogesh Yadav, Paritosh Shukla and Ram Sagar

Bioorganic & Medicinal Chemistry, 2024, 113, 117926
DOI: 10.1016/j.bmc.2024.117926

Design, synthesis and molecular docking study of novel quinoline–triazole molecular hybrids as anticancer agents

Rajubai D. Bakale, Amruta N. Bhagat, Udhav V. Mhetre, Shyam V. Londhe, Sanket S. Rathod, Prafulla B. Choudhari and Kishan P. Haval

Journal of Molecular Structure, 2025, 1321, 140072
DOI: 10.1016/j.molstruc.2024.140072

Synthesis, molecular docking study, molecular dynamics simulation and ADMET prediction of new Sulfa drugs having CA II Inhibitory effect and antidiabetic activity

Saliha Alyar, Ümmühan Özdemir Özmen, Şevki Adem, Kelime Erdem and Hamit Alyar

Journal of Molecular Structure, 2025, 1336, 142015
DOI: 10.1016/j.molstruc.2025.142015

Novel Aromatic Heterocycles for Dual MAO A and B Inhibitors: A Promising Strategy for Parkinson's Disease Treatment

Swati, Amir Raza, Bhupendra Singh and Pankaj Wadhwa

ChemistrySelect, 2025, 10
DOI: 10.1002/slct.202404978

Multitarget Compounds Designed for Alzheimer, Parkinson, and Huntington Neurodegeneration Diseases

Eleftheria-Emmanouela Katsoulaki, Dimitrios Dimopoulos and Dimitra Hadjipavlou-Litina

Pharmaceuticals, 2025, 18, 831
DOI: 10.3390/ph18060831

Synthesis of novel sulphonamide derivatives from tunable quinolines with computational studies

Nagesh Dhanaji Chavan, S. Sarveswari and V. Vijayakumar

Sci Rep, 2025, 15
DOI: 10.1038/s41598-025-94817-1

Recent Studies on Heterocyclic Cholinesterase Inhibitors Against Alzheimer's Disease

Fatih Tok

Chemistry & Biodiversity, 2025, 22
DOI: 10.1002/cbdv.202402837

Pursing Quinoline-8-Sulfonamide derivatives for the identification of potent NPPs inhibitors: In silico molecular docking, molecular dynamics simulations and density field theory (DFT) studies

Jamshed Iqbal, Talha Islam, Mariya al-Rashida, Abdul Hameed, Taseer Iftikhar, Julie Pelletier, Jean Sévigny, Salman Alrokayan, Maria Maqbool, Khurshid Ayub and Tajamul Hussain

Results in Chemistry, 2025, 17, 102556
DOI: 10.1016/j.rechem.2025.102556

Role of quinoline and indole-based heterocycles in revolutionizing Alzheimer’s drug discovery: Promising futuristic structural designs

Atukuri Dorababu

The Journal of Pharmacology and Experimental Therapeutics, 2025, 392, 103606
DOI: 10.1016/j.jpet.2025.103606

Synthesis and Monoamine Oxidase Inhibition Properties of (Sulfamoylphenyl)quinoline-4-carboxylic Acids

J. Efimova, A. Shetnev, M. Korsakov, E. Petersen, A. Petzer and J. P. Petzer

Russ J Gen Chem, 2024, 94, 2593
DOI: 10.1134/S1070363224100049

Sulfonamide Inhibitors of Amyloid Aggregation: A Promising Path against Neurodegenerative Diseases

Joana Smirnovienė and Daumantas Matulis

ChemMedChem, 2025
DOI: 10.1002/cmdc.202500324